Determinants of return at work of breast cancer patients: results from the OPTISOINS01 French prospective study

Alexandra Arfi, Sandrine Baffert, Anne-Laure Soilly, Cyrille Huchon, Fabien Reyal, Bernard Asselain, Souhir Neffati, Roman Rouzier, Delphine Héquet, Alexandra Arfi, Sandrine Baffert, Anne-Laure Soilly, Cyrille Huchon, Fabien Reyal, Bernard Asselain, Souhir Neffati, Roman Rouzier, Delphine Héquet

Abstract

Introduction: Return to work (RTW) after breast cancer (BC) is still a new field of research. The factors determining shorter sick leave duration of patients with BC have not been clearly identified. The aim of this study was to describe work during BC treatment and to identify factors associated with sick leave duration.

Materials and methods: An observational, prospective, multicentre study was conducted among women with operable BC. A logbook was given to all working patients to record sociodemographic and work-related data over a 1-year period.

Results: Work-related data after BC were available for 178 patients (60%). The median age at diagnosis was 50 years (27-77), 87.9% of patients had an invasive form of BC and 25.3% a lymph node involvement. 25.9% had a radical surgery and 24.2% had an axillary dissection. Radiotherapy was performed in 90.9% of patients and chemotherapy in 48.1%. Sick leave was prescribed for 165 patients (92.7%) for a median of 155 days. On univariate analysis, invasive BC (p=0.025), lymph node involvement (p=0.005), radical surgery (p=0.025), axillary dissection (p=0.004), chemotherapy (p<0.001), personal income <€1900/month (p=0.03) and not having received the patient information booklet on RTW (p=0.047) were found to be associated with a longer duration of sick leave. On multivariate analysis, chemotherapy was found to be associated with longer sick leave (OR: 3.5; 95% CI 1.6 to 7.9; p=0.002). The cost of sick leave to French National Health Insurance was fourfold higher in the case of chemotherapy (p<0.001).

Conclusion: Advanced disease and chemotherapy are major factors that influence sick leave duration during the management of BC.

Trial registration number: NCT02813317.

Keywords: breast tumours; public health.

Conflict of interest statement

Competing interests: None declared.

© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Figures

Figure 1
Figure 1
Percentage of patients on sick leave at 1-year follow-up depending on the presence or absence of chemotherapy.
Figure 2
Figure 2
Percentage of patients on sick leave at 1-year follow-up depending on whether or not they had been given the work information booklet.

References

    1. American Cancer Society, Inc. Breast Cancer Facts & figures 2013-2014 (2013) Atlanta. (accessed 20 Sep 2014).
    1. Verdecchia A, Francisci S, Brenner H, et al. . Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. Lancet Oncol 2007;8:784–96. 10.1016/S1470-2045(07)70246-2
    1. Mehnert A, de Boer A, Feuerstein M. Employment challenges for cancer survivors. Cancer 2013;119(Suppl 11):2151–9. 10.1002/cncr.28067
    1. Balak F, Roelen CA, Koopmans PC, et al. . Return to work after early-stage breast cancer: a cohort study into the effects of treatment and cancer-related symptoms. J Occup Rehabil 2008;18:267–72. 10.1007/s10926-008-9146-z
    1. de Boer AG, Taskila TK, Tamminga SJ, et al. . Interventions to enhance return-to-work for cancer patients. Cochrane Database Syst Rev 2015:CD007569 10.1002/14651858.CD007569.pub3
    1. Fantoni SQ, Peugniez C, Duhamel A, et al. . Factors related to return to work by women with breast cancer in northern France. J Occup Rehabil 2010;20:49–58. 10.1007/s10926-009-9215-y
    1. Hedayati E, Johnsson A, Alinaghizadeh H, et al. . Cognitive, psychosocial, somatic and treatment factors predicting return to work after breast cancer treatment. Scand J Caring Sci 2013;27:380–7. 10.1111/j.1471-6712.2012.01046.x
    1. Lavigne JE, Griggs JJ, Tu XM, et al. . Hot flashes, fatigue, treatment exposures and work productivity in breast cancer survivors. J Cancer Surviv 2008;2:296–302. 10.1007/s11764-008-0072-z
    1. Baffert S, Hoang HL, Brédart A, et al. . The patient-breast cancer care pathway: how could it be optimized? BMC Cancer 2015;15:394 10.1186/s12885-015-1417-4
    1. ARC Foundation. Le retour au travail après un cancer: Brochure: Le retour au travail après un cancer; .
    1. R Foundation for Statistical Computing, Vienna, Austria. R Core Team (2012) R: a language and environment for statistical computing. ISBN 3-900051-07-0 [ (last accessed 20 Nov 2016).
    1. Jagsi R, Hawley ST, Abrahamse P, et al. . Impact of adjuvant chemotherapy on long-term employment of survivors of early-stage breast cancer. Cancer 2014;120:1854–62. 10.1002/cncr.28607
    1. Johnsson A, Fornander T, Rutqvist LE, et al. . Predictors of return to work ten months after primary breast cancer surgery. Acta Oncol 2009;48:93–8. 10.1080/02841860802477899
    1. Eaker S, Wigertz A, Lambert PC, et al. . Breast cancer, sickness absence, income and marital status. A study on life situation 1 year prior diagnosis compared to 3 and 5 years after diagnosis. PLoS One 2011;6:e18040 10.1371/journal.pone.0018040
    1. de Ruiter MB, Reneman L, Boogerd W, et al. . Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer. Hum Brain Mapp 2011;32:1206–19. 10.1002/hbm.21102
    1. Reinertsen KV, Cvancarova M, Loge JH, et al. . Predictors and course of chronic fatigue in long-term breast cancer survivors. J Cancer Surviv 2010;4:405–14. 10.1007/s11764-010-0145-7
    1. Islam T, Dahlui M, Majid HA, et al. . Factors associated with return to work of breast cancer survivors: a systematic review. BMC Public Health 2014;14(Suppl 3):S8 10.1186/1471-2458-14-S3-S8
    1. Munir F, Burrows J, Yarker J, et al. . Women’s perceptions of chemotherapy-induced cognitive side affects on work ability: a focus group study. J Clin Nurs 2010;19:1362–70. 10.1111/j.1365-2702.2009.03006.x
    1. Hoving JL, Broekhuizen ML, Frings-Dresen MH. Return to work of breast cancer survivors: a systematic review of intervention studies. BMC Cancer 2009;9:117 10.1186/1471-2407-9-117
    1. Nesvold IL, Fosså SD, Holm I, et al. . Arm/shoulder problems in breast cancer survivors are associated with reduced health and poorer physical quality of life. Acta Oncol 2010;49:347–53. 10.3109/02841860903302905
    1. Assis MR, Marx AG, Magna LA, et al. . Late morbidity in upper limb function and quality of life in women after breast cancer surgery. Braz J Phys Ther 2013;17:236–43. 10.1590/S1413-35552012005000088
    1. Devoogdt N, Van Kampen M, Christiaens MR, et al. . Short- and long-term recovery of upper limb function after axillary lymph node dissection. Eur J Cancer Care 2011;20:77–86. 10.1111/j.1365-2354.2009.01141.x
    1. Hayes SC, Rye S, Battistutta D, et al. . Upper-body morbidity following breast cancer treatment is common, may persist longer-term and adversely influences quality of life. Health Qual Life Outcomes 2010;8:92 10.1186/1477-7525-8-92
    1. Stubblefield MD, Keole N. Upper body pain and functional disorders in patients with breast cancer. Pm R 2014;6:170–83. 10.1016/j.pmrj.2013.08.605
    1. Boyages J, Kalfa S, Xu Y, et al. . Worse and worse off: the impact of lymphedema on work and career after breast cancer. Springerplus 2016;5:657 10.1186/s40064-016-2300-8
    1. Peugniez C, Fantoni S, Leroyer A, et al. . Return to work after treatment for breast cancer: single-center experience in a cohort of 273 patients. Ann Oncol 2010;21:2124–5. 10.1093/annonc/mdq556
    1. Hawkes AL, Gollschewski S, Lynch BM, et al. . A telephone-delivered lifestyle intervention for colorectal cancer survivors ’CanChange': a pilot study. Psychooncology 2009;18:449–55. 10.1002/pon.1527
    1. Sevellec M, Belin L, Bourrillon MF, et al. . [Work ability in cancer patients: Six years assessment after diagnosis in a cohort of 153 workers]. Bull Cancer 2015;102(6 Suppl 1):S5–13. 10.1016/S0007-4551(15)31212-1
    1. Inserm. VICAN2.
    1. Drolet M, Maunsell E, Brisson J, et al. . Not working 3 years after breast cancer: predictors in a population-based study. J Clin Oncol 2005;23:8305–12. 10.1200/JCO.2005.09.500

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅